Seeking $700 million for AI-driven science bets

A fresh-faced VC team, all under forty when they launched last year, is now knocking on doors for cash again. Their goal? To pull together close to three-quarters of a billion dollars for investments where artificial intelligence meets hard science. None of the three partners will go on record, and insiders speaking off the record say the target number is circling seven hundred million. The same trio had already closed two smaller funds inside two years. First came the seed cheque book, then a larger follow-up round. Now they’re back, trying to double the size once more. It’s a rapid escalation—most new firms take half a decade just to reach a third fund—raising questions about whether the speed is sustainable or just hype.Science-heavy startups often need deep pockets and long patience. The partners know this, which is why they’ve carved out a niche: funding businesses that turn AI models into real lab tools, medical diagnostics, or novel materials. Yet raising nearly three-quarters of a billion in today’s tighter funding climate proves they still have to prove their model works at scale. Friends of the firm call it bold. Skeptics call it ambitious. What everyone notices is the short runway between launches—just two years between fund one and fund two, another lightning-fast stride toward fund three. Whether that pace is a strength or a gamble remains the biggest open question.